167 related articles for article (PubMed ID: 28894451)
1. Inflammatory Conditions Dictate the Effect of Mesenchymal Stem or Stromal Cells on B Cell Function.
Luk F; Carreras-Planella L; Korevaar SS; de Witte SFH; Borràs FE; Betjes MGH; Baan CC; Hoogduijn MJ; Franquesa M
Front Immunol; 2017; 8():1042. PubMed ID: 28894451
[TBL] [Abstract][Full Text] [Related]
2. Pediatric Mesenchymal Stem Cells Exhibit Immunomodulatory Properties Toward Allogeneic T and B Cells Under Inflammatory Conditions.
Palomares Cabeza V; Hoogduijn MJ; Kraaijeveld R; Franquesa M; Witte-Bouma J; Wolvius EB; Farrell E; Brama PAJ
Front Bioeng Biotechnol; 2019; 7():142. PubMed ID: 31245368
[TBL] [Abstract][Full Text] [Related]
3. Human adipose tissue-derived mesenchymal stem cells abrogate plasmablast formation and induce regulatory B cells independently of T helper cells.
Franquesa M; Mensah FK; Huizinga R; Strini T; Boon L; Lombardo E; DelaRosa O; Laman JD; Grinyó JM; Weimar W; Betjes MG; Baan CC; Hoogduijn MJ
Stem Cells; 2015 Mar; 33(3):880-91. PubMed ID: 25376628
[TBL] [Abstract][Full Text] [Related]
4. The immunomodulatory effects of human mesenchymal stem cells on peripheral blood mononuclear cells in ALS patients.
Kwon MS; Noh MY; Oh KW; Cho KA; Kang BY; Kim KS; Kim YS; Kim SH
J Neurochem; 2014 Oct; 131(2):206-18. PubMed ID: 24995608
[TBL] [Abstract][Full Text] [Related]
5. Suppression of IL-10 production by activated B cells via a cell contact-dependent cyclooxygenase-2 pathway upregulated in IFN-γ-treated mesenchymal stem cells.
Hermankova B; Zajicova A; Javorkova E; Chudickova M; Trosan P; Hajkova M; Krulova M; Holan V
Immunobiology; 2016 Feb; 221(2):129-36. PubMed ID: 26416211
[TBL] [Abstract][Full Text] [Related]
6. Comparative analysis of human mesenchymal stem cells from fetal-bone marrow, adipose tissue, and Warton's jelly as sources of cell immunomodulatory therapy.
Wang Q; Yang Q; Wang Z; Tong H; Ma L; Zhang Y; Shan F; Meng Y; Yuan Z
Hum Vaccin Immunother; 2016; 12(1):85-96. PubMed ID: 26186552
[TBL] [Abstract][Full Text] [Related]
7. Immunomodulatory Effect of MSC on B Cells Is Independent of Secreted Extracellular Vesicles.
Carreras-Planella L; Monguió-Tortajada M; Borràs FE; Franquesa M
Front Immunol; 2019; 10():1288. PubMed ID: 31244839
[TBL] [Abstract][Full Text] [Related]
8. IFN-gamma and TNF-alpha differentially regulate immunomodulation by murine mesenchymal stem cells.
English K; Barry FP; Field-Corbett CP; Mahon BP
Immunol Lett; 2007 Jun; 110(2):91-100. PubMed ID: 17507101
[TBL] [Abstract][Full Text] [Related]
9. Pre-conditioning mesenchymal stromal cell spheroids for immunomodulatory paracrine factor secretion.
Zimmermann JA; McDevitt TC
Cytotherapy; 2014 Mar; 16(3):331-45. PubMed ID: 24219905
[TBL] [Abstract][Full Text] [Related]
10. Interferon-γ regulates the function of mesenchymal stem cells from oral lichen planus via indoleamine 2,3-dioxygenase activity.
Zhang Z; Han Y; Song J; Luo R; Jin X; Mu D; Su S; Ji X; Ren YF; Liu H
J Oral Pathol Med; 2015 Jan; 44(1):15-27. PubMed ID: 25212102
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-17A-Induced Human Mesenchymal Stem Cells Are Superior Modulators of Immunological Function.
Sivanathan KN; Rojas-Canales DM; Hope CM; Krishnan R; Carroll RP; Gronthos S; Grey ST; Coates PT
Stem Cells; 2015 Sep; 33(9):2850-63. PubMed ID: 26037953
[TBL] [Abstract][Full Text] [Related]
12. Immunomodulatory effects of bone marrow versus adipose tissue-derived mesenchymal stromal cells on NK cells: implications in the transplantation setting.
Blanco B; Herrero-Sánchez MD; Rodríguez-Serrano C; García-Martínez ML; Blanco JF; Muntión S; García-Arranz M; Sánchez-Guijo F; Del Cañizo C
Eur J Haematol; 2016 Dec; 97(6):528-537. PubMed ID: 27118602
[TBL] [Abstract][Full Text] [Related]
13. Interferon-gamma does not break, but promotes the immunosuppressive capacity of adult human mesenchymal stem cells.
Ryan JM; Barry F; Murphy JM; Mahon BP
Clin Exp Immunol; 2007 Aug; 149(2):353-63. PubMed ID: 17521318
[TBL] [Abstract][Full Text] [Related]
14. Mesenchymal stem cells stimulate antibody secretion in human B cells.
Rasmusson I; Le Blanc K; Sundberg B; Ringdén O
Scand J Immunol; 2007 Apr; 65(4):336-43. PubMed ID: 17386024
[TBL] [Abstract][Full Text] [Related]
15. Adipose-derived stromal cells cultured in a low-serum medium, but not bone marrow-derived stromal cells, impede xenoantibody production.
Saka Y; Furuhashi K; Katsuno T; Kim H; Ozaki T; Iwasaki K; Haneda M; Sato W; Tsuboi N; Ito Y; Matsuo S; Kobayashi T; Maruyama S
Xenotransplantation; 2011; 18(3):196-208. PubMed ID: 21696449
[TBL] [Abstract][Full Text] [Related]
16. Effect of inflammatory environment on equine bone marrow derived mesenchymal stem cells immunogenicity and immunomodulatory properties.
Barrachina L; Remacha AR; Romero A; Vázquez FJ; Albareda J; Prades M; Ranera B; Zaragoza P; Martín-Burriel I; Rodellar C
Vet Immunol Immunopathol; 2016 Mar; 171():57-65. PubMed ID: 26964718
[TBL] [Abstract][Full Text] [Related]
17. T Lymphocyte Prestimulation Impairs in a Time-Dependent Manner the Capacity of Adipose Mesenchymal Stem Cells to Inhibit Proliferation: Role of Interferon γ, Poly I:C, and Tryptophan Metabolism in Restoring Adipose Mesenchymal Stem Cell Inhibitory Effect.
Mancheño-Corvo P; Menta R; del Río B; Franquesa M; Ramírez C; Hoogduijn MJ; DelaRosa O; Dalemans W; Lombardo E
Stem Cells Dev; 2015 Sep; 24(18):2158-70. PubMed ID: 26058889
[TBL] [Abstract][Full Text] [Related]
18. Skin-Derived Mesenchymal Stem Cells Alleviate Atherosclerosis via Modulating Macrophage Function.
Li Q; Sun W; Wang X; Zhang K; Xi W; Gao P
Stem Cells Transl Med; 2015 Nov; 4(11):1294-301. PubMed ID: 26400926
[TBL] [Abstract][Full Text] [Related]
19. Human embryonic stem cell-derived mesenchymal stromal cells ameliorate collagen-induced arthritis by inducing host-derived indoleamine 2,3 dioxygenase.
Gonzalo-Gil E; Pérez-Lorenzo MJ; Galindo M; Díaz de la Guardia R; López-Millán B; Bueno C; Menéndez P; Pablos JL; Criado G
Arthritis Res Ther; 2016 Apr; 18():77. PubMed ID: 27036118
[TBL] [Abstract][Full Text] [Related]
20. Prostaglandin E2 potentiates mesenchymal stem cell-induced IL-10+IFN-γ+CD4+ regulatory T cells to control transplant arteriosclerosis.
Hsu WT; Lin CH; Chiang BL; Jui HY; Wu KK; Lee CM
J Immunol; 2013 Mar; 190(5):2372-80. PubMed ID: 23359497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
